RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Correction of hypomagnesemia by dapagliflozin in patients with type 2 diabetes: A post hoc analysis of 10 randomized, placebo-controlled trials

Correction of hypomagnesemia by dapagliflozin in patients with type 2 diabetes: A post hoc analysis of 10 randomized, placebo-controlled trials

Add to Collection
RCTs RD Toto, R Goldenberg, GM Chertow, V Cain… - Journal of Diabetes and …, 2019 - Elsevier

Chapter : Section2, Section9
Journal Year : 2019
Cited by : 30

… in 14%–48% of patients with type 2 diabetes (T2D) and is associated with increased insulin … release, thus minimizing the risk of hypoglycemia. Notably, the antihyperglycemic effect of …..... Read More

Keywords : ['randomize placebocontrolle trial', 'post hoc analysis', 'type diabetes', 'patient', 'hypomagnesemia', 'dapagliflozin', 'correction']
PubMed Link : https://www.sciencedirect.com/science/article/pii/S1056872719305252
Google Scholar Link : https://scholar.google.com/scholar?cites=17266567933372233625&as_sdt=2005&sciodt=0,5&hl=en&num=20